These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26434911)

  • 1. Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer.
    Duman E; Yildirim M; Kaya V; Ozturk D; Inal A; Akarsu Z; Gunduz S; Yildiz M
    Asian Pac J Cancer Prev; 2015; 16(15):6779-82. PubMed ID: 26434911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
    Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
    Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.
    Torre-Bouscoulet L; Arroyo-Hernández M; Martínez-Briseño D; Muñoz-Montaño WR; Gochicoa-Rangel L; Bacon-Fonseca L; Pérez-Padilla R; Vergara E; García-Sancho C; Lozano-Ruiz F; Fernández-Plata R; Guzmán-Barragán A; Arrieta O
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):910-918. PubMed ID: 29976503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary rehabilitation during induction chemoradiotherapy for lung cancer improves pulmonary function.
    Tarumi S; Yokomise H; Gotoh M; Kasai Y; Matsuura N; Chang SS; Go T
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):569-73. PubMed ID: 25451483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.
    Gopal R; Starkschall G; Tucker SL; Cox JD; Liao Z; Hanus M; Kelly JF; Stevens CW; Komaki R
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):114-20. PubMed ID: 12694829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
    Margaritora S; Cesario A; Cusumano G; Cafarotti S; Corbo GM; Ferri L; Ceppi M; Meacci E; Valente S; D'Angelillo RM; Russo P; Porziella V; Bonassi S; Pasqua F; Sterzi S; Granone P
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1457-63. PubMed ID: 20363001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of lung function measurements for the assessment of chemotherapy in lung cancer patients.
    Pinson P; Klastersky J
    Lung Cancer; 1998 Mar; 19(3):179-84. PubMed ID: 9631365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
    Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y
    Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
    Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L
    Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can Pulmonary Rehabilitation during Preoperative Chemoradiotherapy for Non-small Cell Lung Cancer Improve the Respiratory Function?].
    Tokunaga Y; Tarumi S; Yokomise H
    Kyobu Geka; 2016 Jan; 69(1):47-52. PubMed ID: 26975643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Warner A; Dahele M; Hu B; Palma DA; Senan S; Oberije C; Tsujino K; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; De Ruyck K; De Dios NR; Bradley JD; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):612-20. PubMed ID: 26867890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
    Eberhardt WE; Gauler TC; Lepechoux C; Stamatis G; Bildat S; Krbek T; Welter S; Grunenwald D; Fischer B; Rodrigo Hde L; Theegarten D; Le Chevalier T; Seeber S; Stuschke M; Poettgen C
    Lung Cancer; 2013 Oct; 82(1):83-9. PubMed ID: 23957964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient].
    Terashima T; Iwami E; Chubachi S; Ikemura S; Nakajima T; Matsuzaki T; Aoyagi H
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):99-101. PubMed ID: 26809534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
    von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
    Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer.
    Kreuter M; Vansteenkiste J; Herth FJ; Fischer JR; Eberhardt W; Zuna I; Reinmuth N; Griesinger F; Thomas M;
    Respiration; 2014; 87(3):204-10. PubMed ID: 24192055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer.
    Hasegawa T; Futamura Y; Horiba A; Yoshida T; Suzuki T; Kato T; Kaito D; Ohno Y; Iida T; Hayashi S; Sawa T
    J Radiat Res; 2016 Jan; 57(1):50-4. PubMed ID: 26442970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.